GTCR Invests $300M Into New Life Sciences Acquisition Co.

Law360, New York (March 18, 2014, 1:20 PM EDT) -- Private equity firm GTCR on Tuesday said it's partnering with two former executives of molecular diagnostics company Gen-Probe to form a new San Diego life sciences acquisition company, with GTCR investing $300 million of equity capital.

The new entity, Maravai Life Sciences Inc., will focus on diagnostics and health care companies.  Its leadership will include Carl Hull and Eric Tardiff, who served as CEO and senior vice president at Gen-Probe, which merged with diagnostics company Hologic in 2012.

“We are very excited to partner with Carl...
To view the full article, register now.